Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   alpha-Arylidene Diacylglycerol-Lactones (DAG-Lactones) as Selective Ras Guanine-Releasing Protein 3 (RasGRP3) Ligands
  2. Ann, Jihyae; Czikora, Agnes; Saini, Amandeep S.; Zhou, Xiaoling; Mitchell, Gary A.; Lewin, Nancy E.; Peach, Megan; Blumberg, Peter M.; Lee, Jeewoo
  3. Journal of Medicinal Chemistry. 2018, Jul 26; 61(14): 6261-6276.
  1. 2.   Matriptase/epithin participates in mammary epithelial cell growth and morphogenesis through HGF activation
  2. Lee, S. L.; Huang, P. Y.; Roller, P.; Cho, E. G.; Park, D.; Dickson, R. B.
  3. Mechanisms of Development. 2010, Jan-Feb; 127(1-2): 82-95.
  1. 3.   Arylstibonic acids: Novel inhibitors and activators of human topoisomerase IB
  2. Kim, H.; Cardellina, J. H.; Akee, R.; Champoux, J. J.; Stivers, J. T.
  3. Bioorganic Chemistry. 2008 36(4-6): 190-197.
  1. 4.   Coactivators and corepressors of NF-kappa B in I kappa Beta alpha gene promoter
  2. Gao, Z. G.; Chiao, P.; Zhang, X.; Zhang, X. H.; Lazar, M. A.; Seto, E.; Young, H. A.; Ye, J. P.
  3. Journal of Biological Chemistry. 2005, JUN 3; 280(22): 21091-21098.
  1. 5.   The search for novel drug leads for predominately antitumor therapies by utilizing mother nature's pharmacophoric libraries
  2. Kingston, D. G. I.; Newman, D. J.
  3. Current Opinion in Drug Discovery & Development. 2005, MAR; 8(2): 207-227.
  1. 6.   Quantitative kinetic analysis of the bacteriophage lambda genetic network
  2. Kobiler, O.; Rokney, A.; Friedman, N.; Court, D. L.; Stavans, J.; Oppenheim, A. B.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005 102(12): 4470-4475.
  1. 7.   Assay for ubiquitin ligase activity: High-throughput screen for inhibitors of HDM2
  2. Davydov, I. V.; Woods, D.; Safiran, Y. J.; Oberoi, P.; Fearnhead, H. O.; Fang, S.; Jensen, J. P.; Weissman, A. M.; Kenten, J. H.; Vousden, K. H.
  3. Journal of Biomolecular Screening. 2004, DEC; 9(8): 695-703.
  1. 8.   Conformationally constrained analogues of diacylglycerol (DAG). 23. Hydrophobic ligand-protein interactions versus ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C)
  2. Tamamura, H.; Sigano, D. M.; Lewin, N. E.; Peach, M. L.; Nicklaus, M. C.; Blumberg, P. M.; Marquez, V. E.
  3. Journal of Medicinal Chemistry. 2004, SEP 23; 47(20): 4858-4864.
  1. 9.   C/EBP gamma has a stimulatory role on the IL-6 and IL-8 promoters
  2. Gao, H. W.; Parkin, S.; Johnson, P. F.; Schwartz, R. C.
  3. Journal of Biological Chemistry. 2002 277(41): 38827-38837.
  1. 10.   Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid- responsive promoters by binding directly to p300/CBP coactivators
  2. Kino, T.; Gragerov, A.; Slobodskaya, O.; Tsopanomichalou, M.; Chrousos, G. P.; Pavlakis, G. N.
  3. Journal of Virology. 2002 76(19): 9724-9734.
  1. 11.   Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex
  2. Kino, T.; Slobodskaya, O.; Pavlakis, G. N.; Chrousos, G. P.
  3. Journal of Biological Chemistry. 2002 277(4): 2396-2405.
  1. 12.   Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER)
  2. Bodor, J.; Feigenbaum, L.; Bodorova, J.; Bare, C.; Reitz, M. S.; Gress, R. E.
  3. Journal of Leukocyte Biology. 2001 69(6): 1053-1059.
  1. 13.   Acetyltransferases and tumour suppression
  2. Phillips, A. C.; Vousden, K. H.
  3. Breast Cancer Research. 2000 2(4): 244-246.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel